WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Stock Ownership - Who owns Amylyx Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amylyx Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Justin B. KleeCo-Chief Executive Officer2025-03-3121,490$3.47
$74.46kSell
Camille L. BedrosianChief Medical Officer2025-03-3112,425$3.47
$43.08kSell
Gina MazzarielloChief Legal Officer2025-03-319,192$3.48
$31.95kSell
James M. FratesChief Financial Officer2025-03-3110,896$3.47
$37.81kSell
Joshua B. CohenCo-Chief Executive Officer2025-03-3121,490$3.47
$74.48kSell
Bernhardt G. ZeiherDirector2025-03-2010,000$3.70
$37.00kBuy
Justin B. KleeCo-Chief Executive Officer2025-03-034,595$3.15
$14.48kSell
Joshua B. CohenCo-Chief Executive Officer2025-03-034,595$3.17
$14.55kSell
Gina MazzarielloChief Legal Officer2025-03-031,611$3.12
$5.02kSell
Gina MazzarielloChief Legal Officer2025-02-244,169$3.15
$13.14kSell

1 of 3

AMLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMLX insiders and whales buy or sell their stock.

AMLX Shareholders

What type of owners hold Amylyx Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morningside Venture Investments Ltd29.45%26,091,760$110.37MInsider
Isaac Cheng11.76%10,422,228$44.09MInsider
Perceptive Advisors LLC7.65%6,774,348$28.66MInstitution
Invest 1. Bv Als6.65%5,895,280$24.94MInsider
Tcg Crossover Management LLC5.24%4,643,812$19.64MInstitution
Joshua B. Cohen3.79%3,355,280$14.19MInsider
Justin B. Klee3.79%3,355,276$14.19MInsider
Vanguard Group Inc3.04%2,692,489$11.39MInstitution
Bank Of America Corp2.74%2,426,263$10.26MInstitution
Dragsa 96 LLC2.60%2,300,000$9.73MInsider

1 of 3

AMLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMLX47.36%52.64%Net BuyingNet Selling
MNMD48.11%51.89%Net SellingNet Selling
DNA9.80%90.20%Net SellingNet Selling
MAZE0.00%18.22%
TRML56.98%43.02%Net Buying
View Top Biotech Stocks

Amylyx Pharmaceuticals Stock Ownership FAQ

Who owns Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals (NASDAQ: AMLX) is owned by 56.20% institutional shareholders, 62.46% Amylyx Pharmaceuticals insiders, and 0.00% retail investors. Morningside Venture Investments Ltd is the largest individual Amylyx Pharmaceuticals shareholder, owning 26.09M shares representing 29.45% of the company. Morningside Venture Investments Ltd's Amylyx Pharmaceuticals shares are currently valued at $128.37M.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.